Kim DG - Search Results

1

Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma.

Lee MJ, Xu DY, Li H, Yu GR, Leem SH, Chu IS, Kim IH, Kim DG. Lee MJ, et al. Among authors: kim ih, kim dg. Exp Mol Med. 2012 Mar 31;44(3):214-24. doi: 10.3858/emm.2012.44.3.016. Exp Mol Med. 2012. PMID: 22192927 Free PMC article.

2

Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.

Yoo HJ, Yun BR, Kwon JH, Ahn HS, Seol MA, Lee MJ, Yu GR, Yu HC, Hong B, Choi K, Kim DG. Yoo HJ, et al. Among authors: kim dg. Exp Mol Med. 2009 Feb 28;41(2):102-15. doi: 10.3858/emm.2009.41.2.013. Exp Mol Med. 2009. PMID: 19287191 Free PMC article.

3

EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma.

Cui XD, Lee MJ, Yu GR, Kim IH, Yu HC, Song EY, Kim DG. Cui XD, et al. Among authors: kim ih, kim dg. Int J Cancer. 2010 Feb 15;126(4):940-9. doi: 10.1002/ijc.24798. Int J Cancer. 2010. PMID: 19642143

4

Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.

Yun BR, Lee MJ, Kim JH, Kim IH, Yu GR, Kim DG. Yun BR, et al. Among authors: kim ih, kim dg, kim jh. Exp Mol Med. 2010 Nov 30;42(11):787-97. doi: 10.3858/emm.2010.42.11.082. Exp Mol Med. 2010. PMID: 20938215 Free PMC article.

5

Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.

Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG. Wang YP, et al. Among authors: kim dg. Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7. Hepatology. 2013. PMID: 23696034

6

Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.

Hao PP, Li H, Lee MJ, Wang YP, Kim JH, Yu GR, Lee SY, Leem SH, Jang KY, Kim DG. Hao PP, et al. Among authors: kim dg, kim jh. J Hepatol. 2015 Jun;62(6):1278-86. doi: 10.1016/j.jhep.2014.12.033. Epub 2015 Jan 21. J Hepatol. 2015. PMID: 25617504

7

C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling.

Lee S, Lee MJ, Zhang J, Yu GR, Kim DG. Lee S, et al. Among authors: kim dg. Exp Mol Med. 2016 Dec 2;48(12):e275. doi: 10.1038/emm.2016.107. Exp Mol Med. 2016. PMID: 27909336 Free PMC article.

8

OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.

Li H, Zhang J, Lee MJ, Yu GR, Han X, Kim DG. Li H, et al. Among authors: kim dg. Oncotarget. 2017 Mar 14;8(11):18129-18144. doi: 10.18632/oncotarget.15185. Oncotarget. 2017. PMID: 28184024 Free PMC article.

9

Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer.

Kim JH, Lee MJ, Yu GR, Kim SW, Jang KY, Yu HC, Cho BH, Kim DG. Kim JH, et al. Among authors: kim dg, kim sw. Exp Mol Med. 2018 Apr 6;50(4):1-10. doi: 10.1038/s12276-017-0001-1. Exp Mol Med. 2018. PMID: 29622769 Free PMC article.

10

Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.

Yu GR, Kim SH, Park SH, Cui XD, Xu DY, Yu HC, Cho BH, Yeom YI, Kim SS, Kim SB, Chu IS, Kim DG. Yu GR, et al. Among authors: kim sb, kim ss, kim dg, kim sh. Exp Mol Med. 2007 Oct 31;39(5):641-52. doi: 10.1038/emm.2007.70. Exp Mol Med. 2007. PMID: 18059140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,509 results

Search Page

Filters